Litcius/Paper detail

A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients

Peter Winkle, Steven R. Goldsmith, Michael J. Koren, Serge Lepage, Jennifer Hellawell, Ashit Trivedi, Kate Tsirtsonis, Siddique Abbasi, Allegra Kaufman, Richard W. Troughton, Adriaan A. Voors, Jean‐Sébastien Hulot, Erwan Donal, Navid Kazemi, Joel Neutel

2022Cardiovascular Drugs and Therapy36 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAgonistApelinHeart failureReceptorInternal medicineEndocrinologyPharmacologyHuman heartCardiologyApelin-related biomedical researchCardiovascular, Neuropeptides, and Oxidative Stress ResearchInflammation biomarkers and pathways
A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients | Litcius